Home |
Free Dividend Report |
Stock Splits Calendar |
IMMX Stock Split History |
Preferred Stock Newsletter |
IMMX Options Chain |
Stock Message Boards |
Immix Biopharma (IMMX) has 0 splits in our Immix Biopharma stock split history database.
Looking at the Immix Biopharma stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Immix Biopharma shares, starting with a $10,000 purchase of IMMX, presented on a split-history-adjusted basis factoring in the complete Immix Biopharma stock split history.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 12/17/2021 | |
End date: | 05/10/2024 | |
Start price/share: | $4.00 | |
End price/share: | $2.18 | |
Dividends collected/share: | $0.00 | |
Total return: | -45.50% | |
Average Annual Total Return: | -22.39% | |
Starting investment: | $10,000.00 | |
Ending investment: | $5,450.11 | |
Years: | 2.39 |
About Immix Biopharma |
Immix Biopharma is a clinical-stage biopharmaceutical company engaged in the development of a class of Tissue-Specific Therapeutics (TSTx) in oncology and inflammation. Co.'s primary asset, IMX-110, is for the treatment of solid tumors. IMX-110 is a negatively-charged TSTx that simultaneously disables resistance pathways with a poly-kinase inhibitor and induces tumor cell death with an apoptosis inducer, utilizing Co.'s TME Normalization Technology, delivered deep into the tumor micro-environment (TME). Co.'s TME Normalization Technology allows its drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. According to our Immix Biopharma stock split history records, Immix Biopharma has had 0 splits. |
IMMX Split History Table | |
Date | Ratio |
Immix Biopharma Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
Want to receive our latest research absolutely free?
⤹
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.